Compounds for the treatment of inflammatory disorders
US7482370B2 · kind B2 · utility
12Cited by
0References
79Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Jul 13, 2005 |
| Grant date | Jan 27, 2009 |
| Priority date | — |
| Expiry date | Feb 27, 2026 |
Classification
- Technology area (CPC C)Chemistry; Metallurgy
- CPC primaryC07D417/14
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
This invention relates to compounds of the Formula (I):or a pharmaceutically acceptable salt, solvate or isomer thereof, which can be useful for the treatment of diseases or conditions mediated by MMPs, ADAMs, TACE, TNF- or combinations thereof.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.